Mervi E. Hyvönen

1.7k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Mervi E. Hyvönen is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Mervi E. Hyvönen has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Mervi E. Hyvönen's work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Pancreatic function and diabetes (3 papers). Mervi E. Hyvönen is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Pancreatic function and diabetes (3 papers). Mervi E. Hyvönen collaborates with scholars based in Finland, United Kingdom and Australia. Mervi E. Hyvönen's co-authors include Anne Raatikainen-Ahokas, Xiaojuan Meng, Michael W. Hess, Kirsi Sainio, José G. Pichel, Märt Saarma, Heiner Westphal, Merja Lakso, Heikki Rauvala and Maria Lindahl and has published in prestigious journals such as Science, The American Journal of Human Genetics and American Journal Of Pathology.

In The Last Decade

Mervi E. Hyvönen

10 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Cell Fate Decision of Undifferentiated Spermatogonia by GDNF

2000 1.1k citations Xiaojuan Meng, Maria Lindahl et al. Science profile →

Peers

Countries citing papers authored by Mervi E. Hyvönen

Since Specialization

Citations

This map shows the geographic impact of Mervi E. Hyvönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mervi E. Hyvönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mervi E. Hyvönen more than expected).

Fields of papers citing papers by Mervi E. Hyvönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mervi E. Hyvönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mervi E. Hyvönen. The network helps show where Mervi E. Hyvönen may publish in the future.

Co-authorship network of co-authors of Mervi E. Hyvönen

This figure shows the co-authorship network connecting the top 25 collaborators of Mervi E. Hyvönen. A scholar is included among the top collaborators of Mervi E. Hyvönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mervi E. Hyvönen. Mervi E. Hyvönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors 2024 ·The American Journal of Human Genetics ·(unknown), (unknown), (unknown), (unknown), Liliya Euro, Anu Suomalainen, Risto Lapatto, Emilia Kuuluvainen, Ville Hietakangas, Timo Otonkoski, Mervi E. Hyvönen, Kirmo Wartiovaara	8
2	MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks 2022 ·Diabetes Technology & Therapeutics ·Mari‐Anne Pulkkinen, Tero Varimo, Elina Hakonen, (unknown), Mervi E. Hyvönen, (unknown), Sanne Kiiveri, (unknown), Saila Laakso, Karoliina Wehkalampi, Matti Hero, Päivi J. Miettinen, (unknown)	36
3	CRISPR correction of the Finnish ornithine delta-aminotransferase mutation restores metabolic homeostasis in iPSC from patients with gyrate atrophy 2022 ·Molecular Genetics and Metabolism Reports ·(unknown), (unknown), (unknown), Anni I. Nieminen, Mervi E. Hyvönen, Risto Lapatto, Kirmo Wartiovaara	4
4	Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway 2015 ·Cell Death and Disease ·(unknown), Sara Kuusela, Eero Lehtonen, Mervi E. Hyvönen, Matti Ristola, Christopher L. Fogarty, Jukka Tienari, Mariann I. Lassenius, Carol Forsblom, Markku Lehto, Moin A. Saleem, Per‐Henrik Groop, Harry Holthöfer, Sanna Lehtonen	37
5	Early-Onset Diabetic E1-DN Mice Develop Albuminuria and Glomerular Injury Typical of Diabetic Nephropathy 2015 ·BioMed Research International ·Mervi E. Hyvönen, (unknown), Jukka Tienari, Eero Lehtonen, Jarkko Ustinov, (unknown), Hannu Jalanko, Timo Otonkoski, Päivi J. Miettinen, Sanna Lehtonen	10
6	Ezrin Is Down-Regulated in Diabetic Kidney Glomeruli and Regulates Actin Reorganization and Glucose Uptake via GLUT1 in Cultured Podocytes 2014 ·American Journal Of Pathology ·Anita A. Wasik, (unknown), Mervi E. Hyvönen, Luca Musante, Eero Lehtonen, Kerttu Koskenniemi, Jukka Tienari, Antti Vaheri, Dontscho Kerjaschki, (unknown), Csaba Révész, Pekka Varmanen, Tuula A. Nyman, Péter Hamar, Harry Holthöfer, Sanna Lehtonen	27
7	CD2AP is associated with end-stage renal disease in patients with type 1 diabetes 2013 ·Acta Diabetologica ·Mervi E. Hyvönen, Pekka Ihalmo, Niina Sandholm, Monica Stavarachi, Carol Forsblom, Amy Jayne McKnight, Maria Lajer, Anna Maestroni, Gareth Lewis, Lise Tarnow, Silvia Maestroni, Gianpaolo Zerbini, Hans‐Henrik Parving, Alexander P. Maxwell, Per‐Henrik Groop, Sanna Lehtonen	8
8	INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathy 2012 ·Diabetic Medicine ·Mervi E. Hyvönen, Pekka Ihalmo, Carol Forsblom, Lena M. Thorn, Niina Sandholm, Sanna Lehtonen, Per‐Henrik Groop	9
9	Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes 2010 ·Molecular and Cellular Endocrinology ·Mervi E. Hyvönen, (unknown), Anita A. Wasik, Eija Heikkilä, (unknown), Ras Trokovic, Moin A. Saleem, Harry Holthöfer, Sanna Lehtonen	45
10	Regulation of Cell Fate Decision of Undifferentiated Spermatogonia by GDNF breakdown → 2000 ·Science ·Xiaojuan Meng, Maria Lindahl, Mervi E. Hyvönen, Martti Parvinen, Dirk G. de Rooij, Michael W. Hess, Anne Raatikainen-Ahokas, Kirsi Sainio, Heikki Rauvala, Merja Lakso, José G. Pichel, Heiner Westphal, Märt Saarma, Hannu Sariola	1073

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact